Captopril does not acutely modulate plasma endothelin-1 concentration in human congestive heart failure

Congestive heart failure (CHF) is a syndrome characterized by increased levels of angiotensin II (Ang II) and endothelin-1 (ET-1). In vitro, Ang II stimulates ET-1 release. The purpose of the study was to assess the effect of a single dose of an angiotensin-converting enzyme inhibitor (ACEI) captopr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cardiovascular drugs and therapy 1996-11, Vol.10 (5), p.561-565
Hauptverfasser:	GRENIER, O, POUSSET, F, ISNARD, R, KALOTKA, H, CARAYON, A, MAISTRE, G, LECHAT, P, GUEROT, C, THOMAS, D, KOMAJDA, M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Angiotensin II - blood Angiotensin-Converting Enzyme Inhibitors - therapeutic use Biological and medical sciences Captopril - therapeutic use Cardiovascular system Double-Blind Method Endothelin-1 - blood Female Heart Failure - blood Heart Failure - drug therapy Humans Male Medical sciences Middle Aged Pharmacology. Drug treatments Radioimmunoassay Renin - blood Stroke Volume - drug effects Vasodilator agents. Cerebral vasodilators
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!